One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Medication therapy management in dermatology: a call to action
Amaris N. Geisler, Caitlin G. Purvis, Diem-Phuong D. Dao & Steven R. Feldman
doi : 10.1080/09546634.2021.1922571
Pages 373-375 | Received 03 Apr 2021, Accepted 23 Apr 2021, Accepted author version posted online: 28 Apr 2021, Published online:25 May 2021
Role of mannose binding lectin in response to candida antigen immunotherapy of warts
Mohamed Nasr, Ayman Marie, Ghada Boghdadi, Rehab Elsaid & Eman Salah
doi : 10.1080/09546634.2019.1662365
Pages 376-380 | Received 01 Aug 2019, Accepted 25 Aug 2019, Accepted author version posted online: 30 Aug 2019, Published online: 10 Sep 2019
Warts is the commonest cutaneous manifestation of human papillomavirus (HPV) infection. Intralesional Candida antigen immunotherapy is used for wart treatment.
Granuloma annulare: strengthening potential associations and pentoxifylline as a therapeutic option
Michael J. Visconti, Kurt A. Ashack & Richard J. Ashack
doi : 10.1080/09546634.2019.1662366
Pages 381-382 | Received 24 Jul 2019, Accepted 22 Aug 2019, Accepted author version posted online: 29 Aug 2019, Published online: 10 Sep 2019
Granuloma annulare is frequently described in association with numerous systemic conditions and is often refractory to treatment. This retrospective review explored a large patient cohort to further strengthen associated comorbid conditions and assess response to different treatments in patients with granuloma annulare. This study found that patients with granuloma annulare frequently carried a diagnosis of hypothyroidism. Additionally, the highest rate of improvement in any treatment category was seen with pentoxifylline use. Thus, should be further explored as a first-line therapeutic option in the treatment of granuloma annulare.
Evaluation of the effect of combined intralesional injection of prostaglandin F2? with narrow band UVB phototherapy in treatment of resistant cases of vitiligo
Samah A. Eldelee, Shereen F. Gheida, Naglaa I. Sarhan, Zeinab A. Ibrahim & Nashwa N. Elfar
doi : 10.1080/09546634.2019.1658860
Pages 383-390 | Received 19 May 2019, Accepted 13 Aug 2019, Accepted author version posted online: 22 Aug 2019, Published online: 04 Sep 2019
Vitiligo is a chronic cutaneous disease characterized with hypopigmented patches that leave psychological impact on the patients. There is increasing need for new treatment modalities to shorten the duration of treatment of vitiligo with the least side effects.
Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology
Emil A. Tanghetti, Linda Stein Gold, James Q. Del Rosso, Tina Lin, Arturo Angel & Radhakrishnan Pillai
doi : 10.1080/09546634.2019.1668907
Pages 391-398 | Received 12 Aug 2019, Accepted 02 Sep 2019, Accepted author version posted online: 16 Sep 2019, Published online: 26 Sep 2019
Successful clinical data on halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in moderate-to-severe plaque psoriasis are published. This article charts its formulation development.
Off-label studies on tofacitinib in dermatology: a review
Kyle Tegtmeyer, Jeffrey Zhao, Nolan J. Maloney, Giancarlo Atassi, Molly Beestrum & Peter A. Lio
doi : 10.1080/09546634.2019.1673877
Pages 399-409 | Received 10 Sep 2019, Accepted 12 Sep 2019, Published online: 03 Oct 2019
Tofacitinib citrate is an oral Janus kinase 1/3 inhibitor approved for rheumatoid arthritis, ulcerative colitis, and active psoriatic arthritis. Tofacitinib is being increasingly used off-label for dermatological conditions, with varying efficacy across recent studies. A review of these studies will be a helpful resource for dermatologists considering the use of tofacitinib for conditions refractory to first-line therapies.
Letter to the editor submitted in response to “efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial”
Emma Axon & Douglas J. Grindlay
doi : 10.1080/09546634.2019.1659478
Page 410 | Received 15 Aug 2019, Accepted 17 Aug 2019, Accepted author version posted online: 22 Aug 2019, Published online: 02 Sep 2019
Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?
Lutz Schmitz, Jes B. Hansen, Mike Bastian, Thomas Larsson & Eggert Stockfleth
doi : 10.1080/09546634.2019.1662879
Pages 411-417 | Received 24 Jul 2019, Accepted 22 Aug 2019, Accepted author version posted online: 30 Aug 2019, Published online: 13 Sep 2019
It is unclear if there are any distinct AK patient populations that might respond best to a given treatment.
Application of secondary intention for the restoration of the apical triangle after Mohs micrographic surgery
Byung Ho Oh, Yeongjoo Oh, Kyoung Ae Nam, Mi Ryung Roh & Kee Yang Chung
doi : 10.1080/09546634.2019.1666967
Pages 418-423 | Received 07 Aug 2019, Accepted 04 Sep 2019, Published online: 19 Sep 2019
Restoring the apical triangle (AT) to maintain the symmetry of the face after Mohs micrographic surgery can be challenging. We have applied secondary intention (SI) after partial closure in cases with large defects.
Efficacy of doxycycline in the treatment of early stages of mycosis fungoides: a randomized controlled trial
H. El Sayed, S. Shalaby, M. R. E. Abdel-Halim, D. M. Aboelfadl & N. Samir
doi : 10.1080/09546634.2019.1667474
Pages 424-431 | Received 16 Jun 2019, Accepted 07 Sep 2019, Accepted author version posted online: 17 Sep 2019, Published online: 20 Sep 2019
Mycosis fungoides is the most common type of primary cutaneous T cell lymphomas. Doxycycline promoted apoptosis in different human malignant cell lines and in vivo models.
Outcomes of prolonged and low-dose ciclosporin in an Asian population
Ellie Choi, Alex Cook, Crystal Phuan, Aaron Martin, Sam Yang, Derrick Aw & Nisha Suyien Chandran
doi : 10.1080/09546634.2019.1662881
Pages 432-437 | Received 17 Aug 2019, Accepted 25 Aug 2019, Accepted author version posted online: 30 Aug 2019, Published online: 10 Sep 2019
Ciclosporin is used in dermatology for a variety of conditions. Existing guidelines commonly recommend a starting dose of 3–5?mg/kg/day.
A retrospective review of dupilumab and psoriasis biologic combination therapy
Kelly Barry, Pedro Zancanaro, Rachel Casseres, Nicole Dumont & David Rosmarin
doi : 10.1080/09546634.2019.1659481
Pages 438-439 | Received 15 Aug 2019, Accepted 17 Aug 2019, Accepted author version posted online: 23 Aug 2019, Published online: 02 Sep 2019
Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States
Khoa Nguyen, Nazanin Ehsani-Chimeh, Nicole Salame & April W. Armstrong
doi : 10.1080/09546634.2019.1666966
Pages 440-445 | Received 04 Aug 2019, Accepted 07 Sep 2019, Accepted author version posted online: 26 Sep 2019, Published online: 10 Oct 2019
A critical gap exists in determining how various systemic treatments may differentially impact patients’ wage earnings.
Efficacy of long-pulsed Nd-YAG laser in the treatment of nail psoriasis: a clinical and dermoscopic evaluation
Shrook A. Khashaba, Hend Gamil, Reham Salah & Eman Salah
doi : 10.1080/09546634.2019.1668908
Pages 446-452 | Received 28 Jun 2019, Accepted 12 Sep 2019, Accepted author version posted online: 16 Sep 2019, Published online: 24 Sep 2019
Nail psoriasis (NP) is frequently seen in psoriatic patients. It is difficult to treat and shows unsatisfactory response to topical preparations. Recently, different types of Lasers have been shown to be effective in some nail disorders.
Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy
S. Ferrucci, S. Tavecchio, E. Berti & L. Angileri
doi : 10.1080/09546634.2019.1659479
Pages 453-454 | Received 14 Aug 2019, Accepted 17 Aug 2019, Accepted author version posted online: 23 Aug 2019, Published online: 02 Sep 2019
Atopic dermatitis (AD) is a common chronic multifactorial dermatosis that can occur through different clinical phenotypes although all exhibit identical pathogenetic mechanisms such as the prurigo nodularis (PN)-like phenotype.
Association between atopic dermatitis and conjunctivitis in adults: a population-based study in the United States
Kevin K. Wu, Andrea J. Borba, Pierce H. Deng & April W. Armstrong
doi : 10.1080/09546634.2019.1659480
Pages 455-459 | Received 12 Aug 2019, Accepted 17 Aug 2019, Accepted author version posted online: 22 Aug 2019, Published online: 02 Sep 2019
The association between atopic dermatitis (AD) and conjunctivitis in adults has not been well established.
The efficacy and safety of microneedle monopolar radiofrequency for the treatment of periorbital wrinkles
Soon-Hyo Kwon, Ji-Young Choi, Gun Young Ahn, Woo Sun Jang, Jung-Won Shin, Jung-Im Na, Kyoung-Chan Park & Chang-Hun Huh
doi : 10.1080/09546634.2019.1662880
Pages 460-464 | Received 12 Aug 2019, Accepted 22 Aug 2019, Published online: 10 Sep 2019
Treatment of periorbital wrinkles is a challenging task because of its anatomical significance and delicate nature.
Second intention healing of nasal ala and dorsum defects in Asians
Wenyan Jin, Shan Jin, Zhouna Li, Zhehu Jin & Chenglong Jin
doi : 10.1080/09546634.2019.1666204
Pages 465-468 | Received 15 Aug 2019, Accepted 03 Sep 2019, Published online: 17 Sep 2019
Reconstruction of defects of nasal ala and dorsum after surgical excision presents a substantial challenge to dermatologic surgeons. Second intention healing is a simple and extremely useful method to optimize cosmesis after skin cancer removal.
Abnormal liver function tests in acne patients receiving isotretinoin
A. Pona, J. A. Cardenas-de la Garza, W. Haidari, A. Cline, S. R. Feldman & S. L. Taylor
doi : 10.1080/09546634.2019.1662882
Pages 469-472 | Received 16 Aug 2019, Accepted 25 Aug 2019, Published online: 09 Sep 2019
Isotretinoin is an efficacious treatment option for severe acne. Although isotretinoin often causes mild liver enzyme elevation, how acne patients should be monitored on isotretinoin therapy is not well characterized.
Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study
Nirali Patel, Shanice A. McKenzie, Christina L. Harview, Allison K. Truong, Vivian Y. Shi, Lucia Chen, Tristan R. Grogan, Richard G. Bennett & Jennifer L. Hsiao
doi : 10.1080/09546634.2019.1670779
Pages 473-475 | Received 25 Aug 2019, Accepted 12 Sep 2019, Accepted author version posted online: 19 Sep 2019, Published online: 26 Sep 2019
Isotretinoin has been used off-label in hidradenitis suppurativa (HS) patients with variable results, making it difficult to predict which patients with HS are likely to benefit.
